Bouma-Ter Steege JC - Search Results

1

Antiangiogenesis therapy for endometriosis.

Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL, Groothuis PG. Nap AW, et al. Among authors: bouma ter steege jc. J Clin Endocrinol Metab. 2004 Mar;89(3):1089-95. doi: 10.1210/jc.2003-031406. J Clin Endocrinol Metab. 2004. PMID: 15001592

2

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

Dirkx AE, oude Egbrink MG, Castermans K, van der Schaft DW, Thijssen VL, Dings RP, Kwee L, Mayo KH, Wagstaff J, Bouma-ter Steege JC, Griffioen AW. Dirkx AE, et al. Among authors: bouma ter steege jc. FASEB J. 2006 Apr;20(6):621-30. doi: 10.1096/fj.05-4493com. FASEB J. 2006. PMID: 16581970

3

The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.

van der Schaft DW, Dings RP, de Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, Bouma-Ter Steege JC, Wagstaff J, Mayo KH, Griffioen AW. van der Schaft DW, et al. Among authors: bouma ter steege jc. FASEB J. 2002 Dec;16(14):1991-3. doi: 10.1096/fj.02-0509fje. Epub 2002 Oct 18. FASEB J. 2002. PMID: 12397082

4

Angiogenic profile of breast carcinoma determines leukocyte infiltration.

Bouma-ter Steege JC, Baeten CI, Thijssen VL, Satijn SA, Verhoeven IC, Hillen HF, Wagstaff J, Griffioen AW. Bouma-ter Steege JC, et al. Clin Cancer Res. 2004 Nov 1;10(21):7171-8. doi: 10.1158/1078-0432.CCR-04-0742. Clin Cancer Res. 2004. PMID: 15534089

5

Angiostatic proteins and peptides.

Bouma-ter Steege JC, Mayo KH, Griffioen AW. Bouma-ter Steege JC, et al. Crit Rev Eukaryot Gene Expr. 2001;11(4):319-34. Crit Rev Eukaryot Gene Expr. 2001. PMID: 12067070 Review.

6

Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.

Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Bouma-ter Steege JC, Wagstaff J, Griffioen AW. Dirkx AE, et al. Among authors: bouma ter steege jc. Cancer Res. 2003 May 1;63(9):2322-9. Cancer Res. 2003. PMID: 12727857

7

Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activity.

Ahmed B, Van Eijk LI, Bouma-Ter Steege JC, Van Der Schaft DW, Van Esch AM, Joosten-Achjanie SR, Lambin P, Landuyt W, Griffioen AW. Ahmed B, et al. Among authors: bouma ter steege jc. Int J Cancer. 2003 May 20;105(1):20-5. doi: 10.1002/ijc.11010. Int J Cancer. 2003. PMID: 12672025 Free article.

8

Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia.

de Jonge HJ, Weidenaar AC, Ter Elst A, Boezen HM, Scherpen FJ, Bouma-Ter Steege JC, Kaspers GJ, Goemans BF, Creutzig U, Zimmermann M, Kamps WA, de Bont ES. de Jonge HJ, et al. Among authors: bouma ter steege jc. Clin Cancer Res. 2008 Feb 1;14(3):924-30. doi: 10.1158/1078-0432.CCR-07-1821. Clin Cancer Res. 2008. PMID: 18245556

9

Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death.

Weidenaar AC, de Jonge HJ, Fidler V, ter Elst A, Meeuwsen-de Boer T, Douwes J, Bouma-ter Steege JC, Hählen K, Kamps WA, de Bont ES. Weidenaar AC, et al. Among authors: bouma ter steege jc. Anticancer Drugs. 2008 Jan;19(1):45-54. doi: 10.1097/CAD.0b013e3282f1be0b. Anticancer Drugs. 2008. PMID: 18043129 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page